Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation

Triple-negative breast cancers (TNBC) represent a pathological subtype of breast cancer, which are characterized by strong invasiveness, high metastasis rate, low survival rate, and poor prognosis, especially in patients who have developed resistance to multiline treatments. Here, we present a femal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Xu, Wei, Zhuo, Xiaoli, Liu, Lei, Zhang, Junlei, Jiang, Fengxian, Shen, Yanru, Lei, Yan, Hou, Dongsheng, Lin, Xiaoyan, Wang, Cuiyan, Fu, Guobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Precision Medicine Clinic: Molecular Tumor Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243792/
https://www.ncbi.nlm.nih.gov/pubmed/37141396
http://dx.doi.org/10.1093/oncolo/oyad115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243792/
https://www.ncbi.nlm.nih.gov/pubmed/37141396
http://dx.doi.org/10.1093/oncolo/oyad115

Ejemplares similares